Noradrenaline-mediated inhibition by locus coeruleus of spinal trigeminal neurons.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D002415:Cats; D002552:Cerebral Ventricles / Q000502:physiology*; D003213:Conditioning, Psychological; D004298:Dopamine / Q000494:pharmacology; D004347:Drug Interactions; D004558:Electric Stimulation; D004594:Electrophysiology; D005071:Evoked Potentials / Q000187:drug effects; D006651:Histocytochemistry; D007980:Levodopa / Q000494:pharmacology; D008526:Medulla Oblongata / Q000502:physiology; D008856:Microscopy, Fluorescence; D009433:Neural Inhibition; D009434:Neural Pathways; D009474:Neurons / Q000502:physiology*; D018377:Neurotransmitter Agents; D009638:Norepinephrine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology; D013003:Somatosensory Cortex / Q000502:physiology; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D009435:Synaptic Transmission; D013787:Thalamic Nuclei / Q000502:physiology; D014276:Trigeminal Nerve / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*
D002395:Catecholamines; D018377:Neurotransmitter Agents; D012701:Serotonin; D007980:Levodopa; D012110:Reserpine; D004298:Dopamine; D009638:Norepinephrine